Pharmacotherapy of Thyroid Disorders - Live Webinar on January 6, 2025 8PM ET
This course is a vital resource for healthcare professionals, particularly pharmacists, aiming to enhance their understanding of thyroid disorders—a prevalent condition affecting over 12% of the U.S. population.
About this webinar
More than 12% of the U.S. population will develop a thyroid condition during their lifetime. An estimated 20 million Americans have some form of thyroid disease and up to 60 percent of those with thyroid disease are unaware of their condition. Pharmacists are considered the most accessible among healthcare professionals and they should be up to date in their knowledge about the pathology, symptoms, diagnosis and treatment options for thyroid disorders. Ambulatory care pharmacists are required to be knowledgeable about emergency conditions involving thyroid disorders.
The presentation will refresh the audience’s knowledge of the pathophysiology of thyroid disorders to help them understand and identify the biological targets for drug intervention. It will also discuss the different treatment options, their clinical use, and adverse effects.
Pharmacist Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:
Describe the biosynthesis of thyroid hormones
Discuss the targets for pharmacological intervention with thyroid hormones biosynthesis
Explain the treatment strategy of hyperthyroidism and hypothyroidism
Discuss the pharmacology of antithyroid drugs and thyroid hormones
Discuss the management of thyrotoxicosis and hypothyroidism
Other Healthcare Professionals Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:
Describe the symptoms associated with hyperthyroidism and hypothyroidism
List and explain the drugs for treating hyperthyroidism
List and explain the drugs for treating hypothyroidism
Discuss the management of thyrotoxicosis and hypothyroidism
Instructors
Dr. Fandy is both a pharmacist and a pharmaceutical scientist. He practiced pharmacy in Maryland, Vermont, and West Virginia and is currently a Board Certified Geriatric Pharmacist (BCGP). He obtained his Master’s and Ph.D. degrees in pharmaceutical sciences from the University of Southern California and the University of Maryland, respectively. He started his academic career as an Assistant Professor at Albany College of Pharmacy in 2010 and then joined the school of pharmacy at the University of Charleston in 2016, where he serves as the Professor & Chair of the Department of Pharmaceutical & Administrative Sciences. Dr. Fandy is a fellow of the American College of Clinical Pharmacology, and his research focuses on oncology, pharmacology, and experimental therapeutics.